We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Dermatology

Journal Scan / Research · August 12, 2015

Melanocytic Nevi Excised During BRAF Inhibitor Therapy

Journal of the American Academy of Dermatology

 

Additional Info

Journal of the American Academy of Dermatology
Melanocytic Nevi Excised During B-Raf Proto-Oncogene (BRAF) Inhibitor Therapy: A Study of 19 Lesions From 10 Patients
J Am Acad Dermatol 2015 Jul 16;[EPub Ahead of Print], MC Mochel, MR Hammond, DT Frederick, MB Alora-Palli, A Piris, KT Flaherty, MP Hoang

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading